Ortek Therapeutics

Setting a new standard for optimal oral health

Claim My Business
Security Type
Common Stock
Min Investment
Offering Date
May 18, 2022
Expected Close Date
September 06, 2022
Target Raise
No. Investors
Security Price
Number of Employees
Short Term Debt
Cost of Goods
Long Term Debt
Net Income

Company Description

Ortek Therapeutics, Inc. is a medical device and functional food company that has commercialized novel products for the multi-billion dollar professional and consumer oral care markets. Our cutting-edge FDA cleared and patented early cavity detection device, the Ortek-ECD®, helps dental professionals diagnose and monitor cavities without radiation. The ECD can detect early tooth decay often missed by X-rays and other methods. Ortek’s BasicBites® are delicious, candy-like, sugar-free soft chews that are clinically shown to help maintain enamel health using innovative oral microbiome science. Our breakthrough technologies were developed and tested at Stony Brook University School of Dental Medicine. Ortek has entered into an exclusive worldwide license to the ECD patents that are owned by The Research Foundation for The State University of New York.


StartEngine OWNERS Exclusive Click here to learn more

$250+ Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

Early Bird Bonus
Invest $250+ within the first three weeks and receive 10% bonus shares





$250+ Investment
$250+ | 1st Perk
Invest $250+ and receive a onetime $5 off for a single bag of BasicBites.

$1,000+ Investment
$1,000+ | 2nd Perk
Invest 1,000 and receive 5% bonus shares

$2,500+ Investment
$2,500+ | 3rd Perk
Invest $2,500 and receive 10% bonus shares

$5,000+ Investment
$5,000+ | 4th Perk
Invest $5,000+ and receive two free bags of BasicBites and 15% bonus shares

$10,000+ Investment
$10,000+ | 5th Perk
Invest $10,000 and receive four free bags of BasicBites and 20% bonus shares

Key Deal Facts

The Ortek-ECD is a revolutionary FDA cleared device that can help detect the earliest signs of tooth decay that X-rays often miss, while Ortek BasicBites are clinically shown to maintain enamel health by working with the body’s oral microbiome.

Tooth decay is the most prevalent chronic disease in the world, plus about one in four adults suffer from dry mouth.*

President and founder, Mitch Goldberg, has over 35 years of experience in the healthcare industry and previously co-founded Noven Pharmaceuticals, a publicly-traded company that was acquired for $428 million.

Management Team / Advisory Board Bios

Fred Confessore


Mr. Confessore is a senior biomedical and electrical engineer and a member of the Translational Oral Biology and Pathology department at Stony Brook University School of Dental Medicine. Mr. Confessore is a co-inventor of the Ortek-ECD. Mr. Confessore conceived the theory and electrical design for the Ortek-ECD, and provided valuable input for clinical development and regulatory support. Mr. Confessore has worked at Stony Brook University for the past 46 years. During his tenure he contributed to numerous research and development projects and designed, developed, modified equipment and facilities for research programs within the school.

Dr. George Freedman


Dr. George Freedman is a founder and past president, American Academy of Cosmetic Dentistry, a co-founder, Canadian Academy for Esthetic Dentistry, Regent and Fellow, International Academy for Dental Facial Esthetics, and a Diplomate and Chair of the American Board of Aesthetic Dentistry. He is Adjunct Professor of Dental Medicine, Western University, Pomona, California and Professor and Program Director, BPP University, London, UK, MClinDent Programme in Restorative and Cosmetic Dentistry. He is an author of 14 textbooks, and is an internationally renowned lecturer and author of 900 dental articles. He is the International Editor-in-Chief of Dental Tribune and 3D Dentistry, and is on the editorial Boards of Dentistry Today, Oral Health and Dental Asia.

Dr. Howard Glazer


Howard S. Glazer, DDS, FAGD is a Fellow and Past President of the Academy of General Dentistry, and former Assistant Clinical Professor in Dentistry at the Albert Einstein College of Medicine (Bronx, NY), presently he is an Attending Dentist at Englewood Hospital (NJ). He is a Fellow of the American College of Dentists; International College of Dentists; American Society for Dental Aesthetics, the American Academy of Forensic Sciences, and a Diplomat of the American Board of Aesthetic Dentistry. Additionally, Dr. Glazer is the Deputy Chief Forensic Dental Consultant to the Office of Chief Medical Examiner, City of New York. He lectures nationally and internationally and is a frequent author and has been published worldwide.

Anne Nugent Guignon, RDH, MPH, CSP


Anne Nugent Guignon, RDH, MPH, CSP is a highly sought-after international speaker, prolific author, and RDH Magazine feature writer. She is a recognized expert on the oral microbiome, ergonomics, salivary dysfunction, cariology and erosive tooth wear, and employment law matters. Despite her accomplishments, Anne’s clinician heart is always focused on making clinical practice better, easier, and more rewarding. In 2015 she was awarded the CSP, the National Speakers Association’s highest earned credential. Anne is a visionary thinker who has a passion for sharing information. She has received numerous accolades for mentoring, research, and guiding those in healthcare and client services.

Gordon Johnson


Mr. Johnson has been an advisor to Ortek Therapeutics for over 15 years. He has over 30 years of healthcare industry investment banking experience at firms such as First Boston, Kidder Peabody, Piper Jaffray and WR Hambrecht. In addition, he has also held key healthcare industry executive roles including CEO, COO and CFO. Mr. Johnson received his B.A. degree in Biology from the University of Missouri and his M.B.A. degree from Harvard Business School.

Shannon Nanne, RDH


Shannon Nanne, RDH has spent most of her professional career focused on creating awareness of oral cancer and its side effects. She was the executive director of the Global Oral Cancer Forum 2016. She’s authored articles in several publications and has been a key opinion leader for several oral care companies including Ortek. Mrs. Nanne has sat on the Corporate Council for Dimensions of Dental Hygiene for almost two decades and has held an executive board position in the Cleveland Dental Hygiene Association for more than 15 years. Shannon is currently the director of professional relations and education for Curaden, a Swiss oral healthcare company.

Michelle Strange, RDH


Michelle Strange is a practicing traveling registered dental hygienist (RDH) with a career spanning over 20 years. Michelle's primary focus and passion lie in patient care's educational aspects, which she curates for consumers and dental professionals. Michelle has achieved her Master's degree in Dental Hygiene Education focusing on interdisciplinary collaboration. She continues to invest in ongoing education, gaining relevant certifications such as her Certificate in Dental Infection Prevention and Control. Presently, Michelle is a co-founder of Level Up Infection Prevention, A Tale of Two Hygienists Podcast, the Client Success Manager for TeleDent by Mouthwatch, owner of MichelleStrangeRDH.com and TheRoamingDentalHygienist.com.
Amount Raised : $57,935
Reveal the Score by Voting
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
The value of the company compared to similar companies raising money from investors.

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter